- Previous close
99.97 - Open
99.25 - Bid 98.22 x 800
- Ask 99.06 x 1200
- Day's range
98.44 - 99.85 - 52-week range
68.44 - 109.30 - Volume
4,601,248 - Avg. Volume
4,105,685 - Market cap (intra-day)
80.924B - Beta (5Y monthly) 0.40
- PE ratio (TTM)
28.87 - EPS (TTM)
3.43 - Earnings date 25 Oct 2024
- Forward dividend & yield 2.00 (2.02%)
- Ex-dividend date 18 Oct 2024
- 1y target est
107.15
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
www.colgatepalmolive.com34,000
Full-time employees
31 December
Fiscal year ends
Consumer Defensive
Sector
Household & Personal Products
Industry
Recent news: CL
View morePerformance overview: CL
Trailing total returns as of 04/10/2024, which may include dividends or other distributions. Benchmark is .
YTD return
1-year return
3-year return
5-year return
Compare to: CL
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: CL
View moreValuation measures
Market cap
80.92B
Enterprise value
88.49B
Trailing P/E
28.87
Forward P/E
25.51
PEG ratio (5-yr expected)
2.26
Price/sales (ttm)
4.09
Price/book (mrq)
657.92
Enterprise value/revenue
4.43
Enterprise value/EBITDA
19.51
Financial highlights
Profitability and income statement
Profit margin
14.21%
Return on assets (ttm)
16.19%
Return on equity (ttm)
753.33%
Revenue (ttm)
19.99B
Net income avi to common (ttm)
2.84B
Diluted EPS (ttm)
3.43
Balance sheet and cash flow
Total cash (mrq)
1.34B
Total debt/equity (mrq)
1,800.00%
Levered free cash flow (ttm)
2.85B